Authorisation import/export

Since 2 May 2006, a new system for the request and delivery of import and export authorisations is in place.
Pursuant to Regulation (EC) No 273/2004, Council Regulation (EC) No 111/2005, Commission Delegated Regulation (EU) 2015/1011, (EU) 2015/1013 , (EU) 2016/1443) and Commission Delegated Regulation (EU)2018/729, the previous forms (KB 26/10/1993) for import and export authorisations have been replaced by new ones that better comply with the Regulations.

The authorisations are delivered by the Drug Precursors Unit to interested parties.

Requests must be made using the forms below: 

- Request for export authorisation

- Request for import authorisation

Applications for authorisations must be signed by the responsible person or his deputy.

The completed, signed forms and any supporting documents must be sent by e-mail to drugprecursor@fagg-afmps.be

Only signed and correctly completed applications will be declared admissible. The application must bear a manual signature that can subsequently be scanned, or a digital signature that meets the requirements of an electronically qualified signature.

The original application and original supporting documents must be retained and kept available to officials of the Customs and Excise Administration, the Federal Agency for Medicines and Health Products, and officers of the Federal Police.

Return of authorisation copies to the FAMHP Precursors team

Copy No. 3 of the import authorisation shall accompany the scheduled substance from the point of entry into the customs territory of the Union to the business premises of the importer, who shall send this copy to the FAMHP.

Copy No. 2 of the export authorisation shall accompany the scheduled substance and be presented to the customs office where the customs export declaration is made, and subsequently to the competent authority at the point of exit from the customs territory of the Union. The competent authority at the point of exit shall return Copy No. 2 to the FAMHP.

Cancellation

Authorisations that are not used should be returned to the FAMHP Precursors team by post in all copies no later than the expiry date.

Fees

For import or export authorisations issued, a fee is due to the FAMHP.

Request for import authorisation related to scheduled substances pursuant to the Council Regulation (EC) n° 111/2005 of 22 December 2004 laying down rules for the monitoring of trade between the Community and third countries in drug precursors, article 20, pursuant the article 1 “ Drugs Act”

€ 102,50

Request for export authorisation related to scheduled substances pursuant to the Council Regulation (EC) n° 111/2005 of 22 December 2004 laying down rules for the monitoring of trade between the Community and third countries in drug precursors, article 12, pursuant the article 1 “ Drugs Act”

€ 102,50

These fees are indexed each year.

Please note that these fees no longer need to be paid up-front but will be invoiced once the authorisation has been issued.

Last updated on 02/01/2024